Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-41.5
% (year-on-year change in operating income)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2024年12月1日〜2025年2月28日Non-consolidated (standalone)Japanese GAAPNet Sales8,332¥ millionYear on year -0.0%Progress 20.7%
Operating profit797¥ millionYear on year -41.5%Progress 13.0%
Ordinary income805¥ millionYear on year -42.2%Progress 13.1%
Net income attributable to owners of the parent529¥ millionYear on year -43.6%Progress 13.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥23.09
Financial position at period-end
Total assets17,306¥ million
of which net assets 11,304 ¥ millionEquity ratio 65.3%vs. prior year-end +1.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥40,232 million (YoY +13.0%)
Operating profit¥6,130 million (YoY +15.0%)
Ordinary income¥6,145 million (YoY +11.9%)
Net income¥4,041 million (YoY +3.6%)
Annual Dividend Forecast¥92 → ¥94
Factors Behind Changes in Business Performance
生命保険の新規契約実績が想定を下回ったことにより利益の増加が抑制されたこと、及び販売商品構成の改善遅延が影響したこと。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Material subsequent events譲渡制限付株式報酬として自己株式12,252株を処分し、2025年3月21日に払込を完了。処分価額の総額は30,593,244円で、取締役6名に割り当て。
Depreciation and amortization¥111,019 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for investors and analysts)
Issued Shares at Period-End23,001,900
Treasury Shares at Period-End42,007
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 2024年12月1日〜2025年2月28日 |
| Net Sales | ¥8,332 million (YoY -0.0%) |
| Operating profit | ¥797 million (YoY -41.5%) |
| Ordinary income | ¥805 million (YoY -42.2%) |
| Profit attributable to owners of the parent | ¥529 million (YoY -43.6%) |
| Net income per share | ¥23.09 |
| Equity ratio | End of the current fiscal period 65.3 / End of previous period 63.8 |
| Total assets | ¥17,306 million |
| Net assets | ¥11,304 million |
| Full-year earnings forecast | Net Sales ¥40,232 million (YoY +13.0%) / Operating profit ¥6,130 million (YoY +15.0%) / Ordinary income ¥6,145 million (YoY +11.9%) / Net income ¥4,041 million (YoY +3.6%) |
| Annual Dividend Forecast | ¥92 → ¥94 |
| Depreciation and amortization | ¥111,019 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | 譲渡制限付株式報酬として自己株式12,252株を処分し、2025年3月21日に払込を完了。処分価額の総額は30,593,244円で、取締役6名に割り当て。 |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for investors and analysts) |
| Issued Shares at Period-End | 23,001,900 |
| Treasury Shares at Period-End | 42,007 |
| Factors Behind Changes in Business Performance | 生命保険の新規契約実績が想定を下回ったことにより利益の増加が抑制されたこと、及び販売商品構成の改善遅延が影響したこと。 |
Items this document does not state (15)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Changes in the scope of consolidation
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.生命保険の新規契約実績が想定を下回ったことにより利益の増加が抑制されたこと、及び販売商品構成の改善遅延が影響したこと。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.